Loading...
OTCMMKKGY
Market cap62bUSD
Dec 20, Last price  
28.72USD
1D
0.53%
1Q
-18.48%
Name

Merck KGaA

Chart & Performance

D1W1MN
OTCM:MKKGY chart
P/E
4.26
P/S
0.57
EPS
6.48
Div Yield, %
9.21%
Shrs. gr., 5y
-27.52%
Rev. gr., 5y
7.19%
Revenues
20.99b
-5.57%
5,339,500,0005,870,300,0006,258,600,0007,057,100,0007,558,000,0007,747,000,0009,290,600,00010,276,400,00011,172,900,00011,095,100,00011,500,800,00012,844,700,00015,024,000,00015,327,000,00014,836,000,00016,152,000,00017,534,000,00019,687,000,00022,232,000,00020,993,000,000
Net income
2.82b
-15.09%
658,600,000658,900,000983,100,0003,500,100,000367,100,000366,300,000632,100,000606,500,000566,700,0001,202,200,0001,157,300,0001,115,000,0001,629,000,0002,605,000,0003,374,000,0001,320,000,0001,987,000,0003,055,000,0003,326,000,0002,824,000,000
CFO
3.78b
-11.15%
570,900,000732,500,000811,700,0001,218,300,0001,024,000,0001,371,300,0001,782,600,0001,271,200,0002,472,200,0002,225,500,0002,705,500,0002,195,200,0002,518,000,0002,696,000,0002,219,000,0002,856,000,0003,477,000,0004,616,000,0004,259,000,0003,784,000,000
Dividend
Apr 29, 20240.50931 USD/sh
Earnings
Mar 06, 2025

Profile

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
URL
https://www.emdgroup.com/
IPO date
Oct 20, 1995
Employees
59,308
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
20,993,000
-5.57%
22,232,000
12.93%
19,687,000
12.28%
Cost of revenue
16,309,000
16,451,000
14,714,000
Unusual Expense (Income)
NOPBT
4,684,000
5,781,000
4,973,000
NOPBT Margin
22.31%
26.00%
25.26%
Operating Taxes
650,000
948,000
859,000
Tax Rate
13.88%
16.40%
17.27%
NOPAT
4,034,000
4,833,000
4,114,000
Net income
2,824,000
-15.09%
3,326,000
8.87%
3,055,000
53.75%
Dividends
(1,152,000)
(955,000)
(748,000)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
702,000
1,198,000
2,496,000
Long-term debt
9,754,000
9,691,000
8,729,000
Deferred revenue
3,000
3,000
3,000
Other long-term liabilities
3,799,000
2,526,000
3,830,000
Net debt
7,235,000
8,582,000
8,828,000
Cash flow
Cash from operating activities
3,784,000
4,259,000
4,616,000
CAPEX
(1,807,000)
(1,806,000)
(1,421,000)
Cash from investing activities
(1,892,000)
(2,743,000)
(1,578,000)
Cash from financing activities
(1,732,000)
(1,555,000)
(2,504,000)
FCF
2,009,000
3,026,000
3,099,000
Balance
Cash
2,413,000
1,642,000
1,623,000
Long term investments
808,000
665,000
774,000
Excess cash
2,171,350
1,195,400
1,412,650
Stockholders' equity
22,941,000
21,843,000
16,125,000
Invested Capital
38,329,650
36,053,600
32,955,350
ROIC
10.85%
14.01%
12.92%
ROCE
11.57%
15.00%
13.90%
EV
Common stock shares outstanding
434,778
434,778
434,778
Price
Market cap
EV
EBITDA
6,466,000
7,811,000
6,735,000
EV/EBITDA
Interest
272,000
235,000
272,000
Interest/NOPBT
5.81%
4.07%
5.47%